Inbrain: Carolina Aguilar on Brain-Computer Interfaces

Carolina Aguilar, co-founder of the startup Inbrain, is pursuing ambitious goals in the field of brain-computer interfaces with her company. In a recent interview, she stated that her vision is even greater than that of well-known tech pioneers like Sam Altman and Elon Musk. Aguilar emphasizes that the development of these technologies could not only revolutionize human interaction with machines but also significantly expand our understanding of the human brain. Inbrain focuses on developing interfaces that allow for the direct measurement and interpretation of neural activities. These technologies could find applications in various fields, including medicine, education, and entertainment.

Aguilar highlights that the precise capture of brain activities could open new possibilities for treating neurological disorders. A central goal of Inbrain is to improve the quality of life for individuals with neurological conditions. Aguilar explains that by utilizing brain-computer interfaces, patients with diseases such as Parkinson's or epilepsy may be treated more effectively. The technology could help alleviate symptoms or even address the underlying causes. Research in the field of brain-computer interfaces has gained momentum in recent years.

Aguilar points to numerous studies that demonstrate the potential of these technologies. She emphasizes that Inbrain is not only building on existing technologies but also developing new approaches to optimize the interaction between humans and machines. Another aspect Aguilar addresses is the ethical dimension of the technology. She is aware of the challenges associated with the development of brain-computer interfaces. Issues of privacy and security must be carefully considered to gain users' trust.

Aguilar calls for a transparent discussion about the implications of these technologies. Inbrain has already developed initial prototypes that are set to be tested in clinical trials. Aguilar reports that the first tests have shown promising results. The technology could be used in the near future for the treatment of neurological disorders, representing a significant advancement in medical research. The startup is funded through a combination of venture capital and government grants.

Aguilar emphasizes that support from investors is crucial for the further development of the technology. Inbrain plans to conduct additional funding rounds in the coming years to advance research and development. Aguilar is optimistic about the future of brain-computer interfaces. She believes that these technologies could not only revolutionize medicine but also change people's daily lives. The ability to convert thoughts directly into digital commands could fundamentally alter the way humans interact with technology.

The vision of Inbrain could have far-reaching implications for society. Aguilar is convinced that the development of brain-computer interfaces could be one of humanity's greatest discoveries. "We are only at the beginning of a new era of human-machine interaction," she says. The first clinical trials are scheduled for the first quarter of 2027. Aguilar expects that the results of these studies will be crucial for the further development of the technology.